ArticleBMC cancer2024

Utility and predictive value of the CRAFITY score in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus tyrosine kinase inhibitors and PD-1 inhibitor.

Lijie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.